Literature DB >> 12893283

Identification and characterization of a new pair of immunoglobulin-like receptors LMIR1 and 2 derived from murine bone marrow-derived mast cells.

Hidetoshi Kumagai1, Toshihiko Oki, Kaori Tamitsu, Si Zhou Feng, Masao Ono, Hideaki Nakajima, Ying Chun Bao, Yuko Kawakami, Kazunari Nagayoshi, Neal G Copeland, Debra J Gilbert, Nancy A Jenkins, Toshiaki Kawakami, Toshio Kitamura.   

Abstract

We have identified and characterized two mouse cDNAs in a mouse antigen-stimulated bone marrow-derived mast cell cDNA library, both of which encode type I transmembrane proteins. The genes were closely mapped in the distal region of mouse chromosome 11 and expressed not only in mast cells but also widely in leukocytes. The extracellular domains of their encoded proteins contain a single variable immunoglobulin (Ig) motif sharing about 90% identity with amino acids, showing that they comprise a pair of molecules and belong to the Ig superfamily. We named these molecules leukocyte mono-Ig-like receptor1 and 2 (LMIR1 and 2). The intracellular domain of LMIR1 contains several immunoreceptor tyrosine-based inhibition motifs (ITIMs). When cross-linked, the intracellular domain was tyrosine phosphorylated and capable of recruiting tyrosine phosphatases, SHP-1 and SHP-2 and inositol polyphosphate 5-phosphatase, SHIP. LMIR2, on the other hand, contains a short cytoplasmic tail and a characteristic transmembrane domain carrying two positively charged amino acids associated with three kinds of immunoreceptor tyrosine-based activation motif (ITAM)-bearing molecules, DAP10, DAP12, and FcRgamma. These findings suggest that a new pair of ITIM/ITAM-bearing receptors, LMIR1 and 2, regulate mast cell-mediated inflammatory responses through yet to be defined ligand(s).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12893283     DOI: 10.1016/s0006-291x(03)01245-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells.

Authors:  Venkateswara R Simhadri; John F Andersen; Eric Calvo; Seung-Chul Choi; John E Coligan; Francisco Borrego
Journal:  Blood       Date:  2012-02-01       Impact factor: 22.113

Review 2.  The CD300 molecules: an emerging family of regulators of the immune system.

Authors:  Francisco Borrego
Journal:  Blood       Date:  2013-01-04       Impact factor: 22.113

3.  An immunoglobulin-like receptor, Allergin-1, inhibits immunoglobulin E-mediated immediate hypersensitivity reactions.

Authors:  Kaori Hitomi; Satoko Tahara-Hanaoka; Satoru Someya; Akira Fujiki; Hideaki Tada; Tetsuya Sugiyama; Shiro Shibayama; Kazuko Shibuya; Akira Shibuya
Journal:  Nat Immunol       Date:  2010-06-06       Impact factor: 25.606

4.  Characterization of leukocyte mono-immunoglobulin-like receptor 7 (LMIR7)/CLM-3 as an activating receptor: its similarities to and differences from LMIR4/CLM-5.

Authors:  Yutaka Enomoto; Yoshinori Yamanishi; Kumi Izawa; Ayako Kaitani; Mariko Takahashi; Akie Maehara; Toshihiko Oki; Reiko Takamatsu; Masunori Kajikawa; Toshiyuki Takai; Toshio Kitamura; Jiro Kitaura
Journal:  J Biol Chem       Date:  2010-09-03       Impact factor: 5.157

5.  The CD300e molecule in mice is an immune-activating receptor.

Authors:  Masamichi Isobe; Kumi Izawa; Masahiro Sugiuchi; Tamami Sakanishi; Ayako Kaitani; Ayako Takamori; Akie Maehara; Toshihiro Matsukawa; Mariko Takahashi; Yoshinori Yamanishi; Toshihiko Oki; Shino Uchida; Koichiro Uchida; Tomoaki Ando; Keiko Maeda; Nobuhiro Nakano; Hideo Yagita; Toshiyuki Takai; Hideoki Ogawa; Ko Okumura; Toshio Kitamura; Jiro Kitaura
Journal:  J Biol Chem       Date:  2018-01-22       Impact factor: 5.157

6.  TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury.

Authors:  Yoshinori Yamanishi; Jiro Kitaura; Kumi Izawa; Ayako Kaitani; Yukiko Komeno; Masaki Nakamura; Satoshi Yamazaki; Yutaka Enomoto; Toshihiko Oki; Hisaya Akiba; Takaya Abe; Tadasuke Komori; Yoshihiro Morikawa; Hiroshi Kiyonari; Toshiyuki Takai; Ko Okumura; Toshio Kitamura
Journal:  J Exp Med       Date:  2010-06-21       Impact factor: 14.307

7.  Human CD300C delivers an Fc receptor-γ-dependent activating signal in mast cells and monocytes and differs from CD300A in ligand recognition.

Authors:  Mariko Takahashi; Kumi Izawa; Jun-ichi Kashiwakura; Yoshinori Yamanishi; Yutaka Enomoto; Ayako Kaitani; Akie Maehara; Masamichi Isobe; Shinichi Ito; Toshihiro Matsukawa; Fumio Nakahara; Toshihiko Oki; Masunori Kajikawa; Chisei Ra; Yoshimichi Okayama; Toshio Kitamura; Jiro Kitaura
Journal:  J Biol Chem       Date:  2013-01-31       Impact factor: 5.157

8.  Identification and Characterization of CD300H, a New Member of the Human CD300 Immunoreceptor Family.

Authors:  Kouta Niizuma; Satoko Tahara-Hanaoka; Emiko Noguchi; Akira Shibuya
Journal:  J Biol Chem       Date:  2015-07-28       Impact factor: 5.157

9.  Pattern of DAP12 expression in leukocytes from both healthy and systemic lupus erythematosus patients.

Authors:  Nicolas Schleinitz; Laurent Chiche; Sophie Guia; Gaëlle Bouvier; Julie Vernier; Alexis Morice; Elisabeth Houssaint; Jean Robert Harlé; Gilles Kaplanski; Félix A Montero-Julian; Frédéric Vély
Journal:  PLoS One       Date:  2009-07-16       Impact factor: 3.240

10.  Regulation of Immune Responses by the Activating and Inhibitory Myeloid-Associate Immunoglobuline-Like Receptors (MAIR) (CD300).

Authors:  Akira Shibuya; Chigusa Nakahashi-Oda; Satoko Tahara-Hanaoka
Journal:  Immune Netw       Date:  2009-04-30       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.